Today: 1 May 2026
Browse Category

NYSE:UNH 30 January 2026 - 10 February 2026

UnitedHealth stock price today: UNH ticks up as Medicare Advantage rate clock and ACA probes hang over insurers

UnitedHealth stock price today: UNH ticks up as Medicare Advantage rate clock and ACA probes hang over insurers

UnitedHealth shares rose 0.8% to $278.04 Tuesday after a volatile open, as investors watched Medicare Advantage payment updates and new federal scrutiny of health insurers. The Centers for Medicare & Medicaid Services projected a 0.09% average payment increase for 2027, with final rates due by April 6. House Republicans subpoenaed eight ACA insurers in a subsidy fraud probe; UnitedHealth was not named. Managed care stocks were mixed.
10 February 2026
·
UnitedHealth stock price slips after hours as investors brace for early-April Medicare rate call

UnitedHealth stock price slips after hours as investors brace for early-April Medicare rate call

UnitedHealth shares slipped 0.3% to $275.70 in after-hours trading Monday, while the S&P 500 and Nasdaq closed higher. Healthcare stocks lagged as investors eyed Medicare Advantage reimbursement and cost trends ahead of key policy updates. Humana dropped 2.3%, CVS Health fell 3.3%, and Cigna rose 0.8%. UnitedHealth last month warned of its first revenue decline in decades if proposed Medicare rates hold.
10 February 2026
····
UnitedHealth stock price today: UNH ticks up as Medicare Advantage rates and U.S. data loom

UnitedHealth stock price today: UNH ticks up as Medicare Advantage rates and U.S. data loom

UnitedHealth shares rose 0.3% to $277.44 in late morning trading Monday after CMS signaled a 0.09% Medicare Advantage payment increase for 2027. The stock remains under pressure after a 19% drop on Jan. 27, when the company warned of its first revenue decline since 1989. U.S. stocks were mixed, with the Dow down 0.3%. Comments on the CMS proposal are due by Feb. 25.
9 February 2026
··
UnitedHealth stock heads into Monday after UNH’s 3% jump — what investors watch next

UnitedHealth stock heads into Monday after UNH’s 3% jump — what investors watch next

UnitedHealth shares rose 3% Friday to $276.65 after a volatile week for managed-care stocks. Investors await insurer earnings from CVS Health on Feb. 10 and Humana on Feb. 11 for updates on Medicare Advantage trends. The Centers for Medicare and Medicaid Services has proposed a 0.09% payment increase for 2027 plans. The comment period on the 2027 rate notice closes Feb. 25.
8 February 2026
···
UnitedHealth stock price ticks up to $276.65 as insurer cost signals shift — what investors watch next week

UnitedHealth stock price ticks up to $276.65 as insurer cost signals shift — what investors watch next week

UnitedHealth shares closed up 3% at $276.65 Friday, rebounding after Molina Healthcare’s weak 2026 outlook rattled managed-care stocks. Centene later issued a stronger 2026 profit forecast, easing some pressure. UnitedHealth traded between $263.00 and $277.74 during the session. Investors await Humana’s results Feb. 11 and a Medicare Advantage rate decision April 6.
7 February 2026
·
UnitedHealth stock rebounds after hours as UNH recoups losses; Medicare rate debate looms

UnitedHealth stock rebounds after hours as UNH recoups losses; Medicare rate debate looms

UnitedHealth shares rose 3.4% to $277.57 Friday and gained another 3% after hours, rebounding after a volatile week for health insurers. Mizuho cut its price target on the stock to $350, citing delayed earnings recovery. Medicare Advantage rates and medical-cost trends remain key concerns. The Dow closed above 50,000, marking the strongest market gains in months.
7 February 2026
····
UnitedHealth (UNH) stock rebounds nearly 2% as sector digests cost shock, Mizuho trims target

UnitedHealth (UNH) stock rebounds nearly 2% as sector digests cost shock, Mizuho trims target

UnitedHealth shares rose 1.9% to $273.79 Friday, rebounding after Molina Healthcare’s weak 2026 profit outlook sent sector stocks tumbling Thursday. Mizuho cut its price target for UnitedHealth to $350 but kept an Outperform rating. Investors await the April 6 CMS decision on 2027 Medicare Advantage rates. Molina shares plunged nearly 28%, while Centene fell 5.5% and Cigna gained about 3%.
6 February 2026
·
UnitedHealth stock falls again after FTC insulin deal puts OptumRx back in focus

UnitedHealth stock falls again after FTC insulin deal puts OptumRx back in focus

UnitedHealth shares fell nearly 3% to $275.92 in after-hours trading Wednesday after the FTC announced a 10-year insulin pricing settlement with Cigna’s Express Scripts, increasing scrutiny on OptumRx and CVS Caremark. Investors are watching for an FTC oral argument Feb. 5 and a House hearing on drug prices Feb. 11. CVS and Cigna shares also declined. UnitedHealth did not comment.
5 February 2026
·····
UnitedHealth stock bounces even after Truist, JPMorgan trim targets as Medicare Advantage rates loom

UnitedHealth stock bounces even after Truist, JPMorgan trim targets as Medicare Advantage rates loom

UnitedHealth shares rose 1% to $289.75 Monday, outperforming peers as Humana, Elevance, and Cigna declined. Truist and JPMorgan cut price targets but kept positive ratings. Investors focused on Medicare Advantage payment rates and 2026 cost trends after last week’s sector sell-off. Final 2027 Medicare Advantage rates are expected in April.
2 February 2026
·······
UnitedHealth stock: the Medicare Advantage deadline that could drive UNH’s next move

UnitedHealth stock: the Medicare Advantage deadline that could drive UNH’s next move

UnitedHealth Group shares fell 1.8% to $286.93 Friday as investors weighed the government’s proposed 2027 Medicare Advantage rates. The Centers for Medicare & Medicaid Services set a Feb. 25 deadline for comments and plans to announce final rates by April 6. UnitedHealth’s stock had plunged nearly 20% earlier in the week after the initial rate proposal missed analyst expectations.
1 February 2026
·
Healthcare stocks hold up as defensive bid lingers; Pfizer, Merck earnings set the tone

Healthcare stocks hold up as defensive bid lingers; Pfizer, Merck earnings set the tone

The Health Care Select Sector SPDR Fund (XLV) rose 0.6% to $154.74 Friday, while the S&P 500 fell 0.43%. Healthcare and consumer staples were the only S&P sectors in positive territory as investors shifted to defensive stocks. Major managed-care shares lagged after a minimal proposed Medicare Advantage rate hike. Pfizer, Merck, and Eli Lilly report earnings next week.
1 February 2026
·····
Dow Jones today: Warsh Fed pick and hot inflation data hang over Monday’s open

Dow Jones today: Warsh Fed pick and hot inflation data hang over Monday’s open

The Dow fell 179.09 points, or 0.4%, to 48,892.47 Friday after Trump named Kevin Warsh as his pick for Fed chair and producer inflation came in hotter than expected. Thom Tillis said he would block Warsh’s confirmation until a Justice Department probe into Powell ends. The S&P 500 dropped 0.43%, Nasdaq lost 0.94%. The January U.S. jobs report is due next Friday.
1 February 2026
········
UnitedHealth stock slips again after Barclays trims target — here’s what traders are watching next

UnitedHealth stock slips again after Barclays trims target — here’s what traders are watching next

UnitedHealth shares fell 1.8% to $286.93 in after-hours trading Friday after Barclays cut its price target. The stock has dropped about 18% since Monday, triggered by a 20% plunge Tuesday. UnitedHealth forecast 2026 revenue just over $439 billion, down 2% from last year, and signaled a medical care ratio of 88.8%. Several banks trimmed price targets this week, citing Medicare-related uncertainty.
31 January 2026
·
UnitedHealth stock dips again as Medicare Advantage rate worries hang over UNH shares

UnitedHealth stock dips again as Medicare Advantage rate worries hang over UNH shares

UnitedHealth Group shares fell 2.1% to $286.12 in late-morning trading Friday, extending losses after this week’s selloff. Investors focused on proposed 2027 Medicare Advantage payment changes, with the government’s comment period ending Feb. 25 and final rates due April 6. CMS projects a net average payment increase of 0.09% for 2027. UBS cut its price target for UnitedHealth to $410, citing rate uncertainty.
30 January 2026
·
1 2 3 4 … 9

Stock Market Today

  • NVIDIA Shares Surge on Robust AI Demand and Strong Financials
    April 30, 2026, 9:46 PM EDT. Investor confidence grows in NVIDIA amid soaring demand for AI computing power. The chipmaker reported Q4 FY2026 revenue of $68.13 billion, a 73.2% annual jump, and full-year revenue of $215.94 billion, highlighting expansion in Data Center Networking with 263% growth. Despite zero revenue from China due to export restrictions, NVIDIA's global orders remain robust, including clients like Meta and OpenAI. Profitability impresses with a 75.2% gross margin and $120 billion net income for the year. Forward price-to-earnings ratio of 26x and PEG of 0.741 reflect a valuation attractive relative to growth. Investors balance enthusiasm with risks from ongoing China export challenges.

Latest article

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

30 April 2026
Nvidia shares dropped 4.6% to $199.57 Thursday as investors reacted to Alphabet and Amazon expanding sales of their own AI chips. Alphabet reported Google Cloud revenue up 63% and began selling TPU chips directly to customers. AMD and Broadcom shares rose 5.1% and 3.0%, respectively. Amazon said its Trainium chip line secured $225 billion in revenue commitments.
Go toTop